Skip to main content

ADVERTISEMENT

Allan Zeeberg Iversen, MD, PhD

06/03/2010
   ABSTRACT: Background. Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary...
   ABSTRACT: Background. Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary...
   ABSTRACT: Background....
06/03/2010
Journal of Invasive Cardiology
Original Contribution
07/28/2011
Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a...
Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a...
Abstract: Objective. Use of...
07/28/2011
Journal of Invasive Cardiology
Original Contribution
01/05/2012
Abstract: Objective. To describe gender-specific long-term outcome and initiation of secondary preventive medication among patients with acute myocardial infarction (AMI). Design. Observational cohort study. Setting. Nationwide registries....
Abstract: Objective. To describe gender-specific long-term outcome and initiation of secondary preventive medication among patients with acute myocardial infarction (AMI). Design. Observational cohort study. Setting. Nationwide registries....
Abstract: Objective. To describe...
01/05/2012
Journal of Invasive Cardiology